Goldman Sachs
MTEM

Goldman Sachs’s Molecular Templates, Inc. MTEM Stock Holding History

Goldman Sachs’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,173
Closed -$17.4K – 6208
2024
Q2 		$17.4K Buy
+15,173
New +$22.5K ﹤0.01% 5519
2023
Q3 		– Sell
-2,778
Closed -$20K – 6035
2023
Q2 		$20K Buy
2,778
+99
+4% +$677 ﹤0.01% 5548
2023
Q1 		$15.3K Sell
2,679
-740
-22% -$5K ﹤0.01% 5696
2022
Q4 		$16.8K Sell
3,419
-1,785
-34% -$14.8K ﹤0.01% 5719
2022
Q3 		$59K Sell
5,204
-6,068
-54% -$76.3K ﹤0.01% 5782
2022
Q2 		$154K Buy
11,272
+3,189
+39% +$74.6K ﹤0.01% 5731
2022
Q1 		$418K Sell
8,083
-989
-11% -$43.7K ﹤0.01% 5447
2021
Q4 		$534K Buy
9,072
+3,404
+60% +$255K ﹤0.01% 5330
2021
Q3 		$571K Buy
5,668
+2,209
+64% +$228K ﹤0.01% 5117
2021
Q2 		$406K Buy
3,459
+955
+38% +$125K ﹤0.01% 5337
2021
Q1 		$474K Sell
2,504
-1,556
-38% -$273K ﹤0.01% 5165
2020
Q4 		$572K Sell
4,060
-2,231
-35% -$330K ﹤0.01% 4526
2020
Q3 		$1.03M Buy
6,291
+4,023
+177% +$715K ﹤0.01% 4054
2020
Q2 		$469K Buy
2,268
+651
+40% +$151K ﹤0.01% 4411
2020
Q1 		$323K Buy
1,617
+858
+113% +$188K ﹤0.01% 4457
2019
Q4 		$159K Sell
759
-1,471
-66% -$211K ﹤0.01% 4952
2019
Q3 		$220K Buy
2,230
+90
+4% +$8.39K ﹤0.01% 4792
2019
Q2 		$268K Sell
2,140
-594
-22% -$64.5K ﹤0.01% 4665
2019
Q1 		$238K Buy
2,734
+249
+10% +$18.3K ﹤0.01% 4729
2018
Q4 		$151K Buy
2,485
+1,782
+253% +$124K ﹤0.01% 4905
2018
Q3 		$57K Sell
703
-327
-32% -$25.1K ﹤0.01% 5269
2018
Q2 		$81K Sell
1,030
-3,134
-75% -$355K ﹤0.01% 5258
2018
Q1 		$500K Buy
+4,164
New +$627K ﹤0.01% 4492
2017
Q3 		– Sell
-115
Closed -$7K – 6927
2017
Q2 		$7K Sell
115
-7
-6% -$550 ﹤0.01% 6679
2017
Q1 		$11K Sell
122
-661
-84% -$61.9K ﹤0.01% 6609
2016
Q4 		$57K Sell
783
-2
-0.3% -$153 ﹤0.01% 6354
2016
Q3 		$88K Sell
785
-232
-23% -$31.9K ﹤0.01% 6288
2016
Q2 		$107K Sell
1,017
-750
-42% -$53.7K ﹤0.01% 6093
2016
Q1 		$134K Buy
1,767
+1,452
+461% +$85.7K ﹤0.01% 5909
2015
Q4 		$25K Sell
315
-288
-48% -$142K ﹤0.01% 6795
2015
Q3 		$405K Buy
603
+511
+555% +$363K ﹤0.01% 5345
2015
Q2 		$61K Buy
92
+32
+53% +$21.1K ﹤0.01% 6814
2015
Q1 		$40K Sell
60
-61
-50% -$40.2K ﹤0.01% 6761
2014
Q4 		$64K Sell
121
-29
-19% -$14.5K ﹤0.01% 6735
2014
Q3 		$89K Buy
150
+34
+29% +$23.5K ﹤0.01% 6630
2014
Q2 		$76K Sell
116
-19
-14% -$12.6K ﹤0.01% 6657
2014
Q1 		$106K Sell
135
-453
-77% -$368K ﹤0.01% 6378
2013
Q4 		$453K Buy
588
+54
+10% +$40.7K ﹤0.01% 5370
2013
Q3 		$410K Buy
534
+17
+3% +$14K ﹤0.01% 5310
2013
Q2 		$449K Buy
+517
New +$437K ﹤0.01% 5033

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
I
INVST Indianapolis, Indiana $886M AUM 21.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs's MTEM Position: Q3 2024 in Review

Goldman Sachs sold out of Molecular Templates, Inc. (MTEM) in Q3 2024, closing a stake of 15,173 shares — an estimated $17.4K sold.

Goldman Sachs first reported a position in MTEM in Q2 2013 and held it in 40 quarters. The position peaked at $1.03M in Q3 2020. 24 funds tracked by Wall St. Rank hold MTEM as of Q3 2024.

  • Goldman Sachs reported no remaining Molecular Templates, Inc. position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 15,173 Molecular Templates, Inc. shares in Q3 2024, an estimated $17.4K.
  • Goldman Sachs first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 40 quarters.
  • Goldman Sachs's Molecular Templates, Inc. position peaked at $1.03M in Q3 2020.
  • 24 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.